Article

rAAV-Delivered PTEN Therapeutics for Prostate Cancer

2020-11-04

Abstract excerpt

<h4>Background: </h4> Prostate cancer (PCa) is the second most popular diagnosed cancer and the fifth leading cause of cancer-related mortality for males globally. At present, effective treatments for PCa need to be further developed. To further understand the molecular mechanism and develop novel therapeutics for PCa, the role of phosphatase and tensin homolog (PTEN) signaling in PCa progression was investigated....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b0510d40-1c48-5d1b-9f96-62df66a17a88
DOI: 10.21203/rs.3.rs-100289/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

rAAV-Delivered PTEN Therapeutics for Prostate CancerDOI 10.21203/rs.3.rs-100289/v1Read

Biobank of genetically defined murine prostate cancer tumoroids uncovers oncogenic pathways and drug vulnerabilities driven by PTEN-lossSemantic proximity Read

Therapeutic Potential of miRNAs in Prostate Cancer: From Mechanisms to Targeted Therapy and Clinical ApplicationsSemantic proximity Read

The PTEN Conundrum: How to Target PTEN-Deficient Prostate CancerSemantic proximity Read

<em>In Vivo </em>Models for Prostate Cancer ResearchSemantic proximity Read

Pre-Clinical Models to Study Human Prostate CancerSemantic proximity Read

PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancersSemantic proximity Read

Lentiviral vector‐mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcomeSemantic proximity Read

Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.Semantic proximity Read

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.Semantic proximity Read

Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasisSemantic proximity Read

Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatmentSemantic proximity Read

TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN -lossSemantic proximity Read